Incentive Care
OtherICS is a novel intervention that incorporates patient education, social support, and financial assistance to assist individuals.
NCT Number: NCT03264885
Elderly with visual impairment (VI) who undergo community eye screening often do not attend tertiary follow-up even if significant eye diseases are detected. Investigators evaluate an incentive-care scheme (ICS) to improve the attendance rates of tertiary eye-care visits of participants following community eye screening.
Looking for future studies?
Notify Me21 year–80 year
All sexes
Interventional
Not applicable
A randomized controlled study individuals with VI with baseline visual acuity (VA) and vision-related quality of life (VRQoL) assessed in the community. Participants were randomised to either receiving ICS or usual care (UC). ICS is a novel intervention that incorporates patient education, social support, and financial assistance to assist individuals. Participants in UC received a standard GP referral letter advising them to seek further care. Our main outcome measure was compliance to tertiary eye-care referral. Our secondary outcome measure was VA and VRQoL assessed at 3 months.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ICS is a novel intervention that incorporates patient education, social support, and financial assistance to assist individuals.
Time frame: 3 months
Percentage of participants who attended follow-up
Time frame: 3 months
Vision checked on Snellen chart
Singapore National Eye Centre
Other Gov
Randomized Controlled Trial Evaluating an Incentive-based Community Eye-care Programme for Elderly With Visual Impairment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07641127
Behavior, Eye Diseases
Cairo, Egypt
View Trial DetailsNCT06616051
Eye Diseases, Nervous System Diseases
Rawalpindi, Punjab Province, Pakistan
View Trial DetailsNCT07206654
Age-related Macular Degeneration (AMD), Arthralgia
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial DetailsNCT03174314
Eye Diseases, Nervous System Diseases
New York, United States
View Trial Details